Bausch Health Companies Inc.
Bausch Health Companies Inc. is a global healthcare enterprise dedicated to the creation, production, and sale of a diverse array of pharmaceutical, medical device, and over-the-counter items. Headquartered in Laval, Canada, the company is led by CEO Thomas J. Appio. The operations are strategically organized into…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
1D
-0.7%
1W
+3.2%
1M
+11.8%
6M
+10.3%
YTD
-6.4%
1Y
+5.4%
2Y
-23.5%
5Y
-74.7%
10Y
-69.2%
Next earnings date
28/10/2026 (in 11 days)
Volatility around earnings
~68% stronger price swings than usual
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
0
STRONG BUY
7
BUY
11
HOLD
2
SELL
0
STRONG SELL
20
TOTAL · Hold
As of: 27/04/2026
P/E
-2.14
P/B
-1.33
EV/EBITDA
10.41
RETURN ON EQUITY
-14.2%
NET MARGIN
9.0%
DEBT/EQUITY
-11.73
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
88.6%
FLOAT SHARES
331,339,189
AVG. DAILY VOLUME (30D)
508,097
Bausch Health Companies Inc. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Canada.
The CEO is Thomas J. Appio, the company employs around 20,300 people.
The IPO was on 03/04/1996; the stock trades on TSX under the ticker BHC.TO.
20 analysts rate the stock, the consensus is Hold (as of 27/04/2026).
This is an external assessment, not a statement by Market Jury.
The next earnings date is 28/10/2026.
Around past earnings, price swings were roughly 68% stronger than usual.
Yes. The last dividend was CA$1.00 per share, ex-date 10/11/2010, paid on 22/12/2010.
The dividend yield is 0.0% (as of 30/06/2026).
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
Clicking "Analyze stock" lets five strategies assess Bausch Health Companies against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.